Invention Grant
- Patent Title: Antibody and checkpoint inhibitor combination therapy
-
Application No.: US16333065Application Date: 2017-09-14
-
Publication No.: US11655304B2Publication Date: 2023-05-23
- Inventor: Tina Christine Lavranos , Daniel John Inglis , Christopher L. Reyes
- Applicant: Bionomics Limited
- Applicant Address: AU Eastwood
- Assignee: Bionomics Limited
- Current Assignee: Bionomics Limited
- Current Assignee Address: AU Eastwood
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Jeanne M. DiGiorgio, Esq.
- Priority: AU 16903724 2016.09.16
- International Application: PCT/AU2017/050998 2017.09.14
- International Announcement: WO2018/049474A 2018.03.22
- Date entered country: 2019-03-13
- Main IPC: C07K16/30
- IPC: C07K16/30 ; A61P35/00 ; A61K31/343 ; A61K31/4741 ; A61K31/513 ; A61K31/519 ; A61K39/395 ; C07K16/28 ; A61K45/06 ; A61K31/661 ; A61K31/4745 ; A61K39/00
Abstract:
The present invention provides a combination therapy for treatment of a tumour in a subject. The combination therapy comprises administration of (i) an antibody directed against cancer stem cells and (ii) a checkpoint inhibitor.
Public/Granted literature
- US20190263925A1 ANTIBODY AND CHECKPOINT INHIBITOR COMBINATION THERAPY Public/Granted day:2019-08-29
Information query
